Age-related Macular Degeneration

RetinaCME ® Presents Updates from Vancouver: Best of Ophthalmology Research on Improving Outcomes With New Treatment Options for Neovascular Retinal Diseases

RetinaCME® Presents Updates from Vancouver: Best of Ophthalmology Research on Improving Outcomes With New Treatment Options for Neovascular Retinal Diseases

The integration of intravitreal anti-vascular endothelial growth factor (a…

Expiration Date: 5/8/2020

Max Credits: 0.75

View Activity

Improving the Burden of Treatment for Age-related Macular Degeneration through Advances in Delivery

Improving the Burden of Treatment for Age-related Macular Degeneration through Advances in Delivery

Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy h…

Expiration Date: 5/2/2020

Max Credits: 0.75

View Activity

Beyond the Burden: New Options and Regimens for the Treatment of Neovascular Age-related Macular Degeneration

Beyond the Burden: New Options and Regimens for the Treatment of Neovascular Age-related Macular Degeneration

Intravitreal anti-vascular endothelial growth factor (VEGF) therapy has re…

Expiration Date: 4/4/2020

Max Credits: 0.5

View Activity

Keeping an Eye on AMD: Nutritional Strategies to Improve Outcomes

Keeping an Eye on AMD: Nutritional Strategies to Improve Outcomes

Age-related macular degeneration (AMD), which is a leading cause of blindn…

Expiration Date: 3/27/2020

Max Credits: 0.75

View Activity

Retina 2019: What's New in Tie2?

Retina 2019: What's New in Tie2?

The integration of intravitreal anti-vascular endothelial growth factor (V…

Expiration Date: 2/20/2020

Max Credits: 0.75

View Activity

Long-term Management of Neovascular AMD: Meeting the Need for Improvement

Long-term Management of Neovascular AMD: Meeting the Need for Improvement

Age-related macular degeneration (AMD) is a leading cause of irreversible …

Expiration Date: 2/13/2020

Max Credits: 0.75

View Activity

Progressive Pathways in Treating Neovascular Retinal Disease: Exploring Tie2

Progressive Pathways in Treating Neovascular Retinal Disease: Exploring Tie2

The integration of intravitreal anti-vascular endothelial growth factor (V…

Expiration Date: 1/14/2020

Max Credits: 1.25

View Activity

Intravitreal Interventions: Volume 7, Number 4

Intravitreal Interventions: Volume 7, Number 4

The prompt identification and optimal management of retinal vascular disea…

Expiration Date: 10/29/2019

Max Credits: 1.25

View Activity

Long-term Management of AMD: Examining New Evidence

Long-term Management of AMD: Examining New Evidence

Age-related macular degeneration (AMD) is a leading cause of irreversible …

Expiration Date: 10/23/2019

Max Credits: 0.75

View Activity

Rapid Response from Vienna 2018: Seeking the Right Dose of Anti-VEGF Therapy for Age-related Macular Degeneration and Diabetic Retinopathy

Rapid Response from Vienna 2018: Seeking the Right Dose of Anti-VEGF Therapy for Age-related Macular Degeneration and Diabetic Retinopathy

The integration of anti-vascular endothelial growth factor (VEGF) intravit…

Expiration Date: 9/27/2019

Max Credits: 1

View Activity